A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain Metastases

NCT02133677 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer and Breast Cancer Patients With Brain Metastases

Interventions

DRUG: temozolomide 100mg

Sponsor

Far Eastern Memorial Hospital